Pyridine

Pyridine

SCHEMBL7388308

N=C=S.N=C=S.c1ccncc1

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.60
NAPRT Q6XQN6 1/20 0.60
TDP1 Q9NUW8 1/20 0.60
NOTUM Q6P988 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pyridine SCHEMBL2550527 1.00
Pyridine SCHEMBL8773628 0.86
Pyridine SCHEMBL11825158 0.83 TSHR (0.64) TSHRNAPRTTDP1NOTUM
Pyridine SCHEMBL10782362 0.82
Pyridine SCHEMBL1410940 0.80 TSHR (0.60) TSHRNAPRTTDP1NOTUM
Pyrimidine SCHEMBL10509081 0.80
Pyridine SCHEMBL2549030 0.80
Pyridine SCHEMBL28836661 0.80
Pyridine SCHEMBL28012016 0.79
Pyridine SCHEMBL28012452 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119842037-A Polymeric resin and preparation method thereof, optical lens and intelligent glasses 珠海莫界科技有限公司 2025-04-18 CN claimed
CN-119798589-A Polymeric resin and preparation method thereof, optical lens and intelligent glasses 珠海莫界科技有限公司 2025-04-11 CN claimed
CN-119798588-A Polymeric resin and preparation method thereof, optical lens and intelligent glasses 珠海莫界科技有限公司 2025-04-11 CN claimed
CN-119842037-A Polymeric resin and preparation method thereof, optical lens and intelligent glasses 珠海莫界科技有限公司 2025-04-18 CN disclosed
CN-119798588-A Polymeric resin and preparation method thereof, optical lens and intelligent glasses 珠海莫界科技有限公司 2025-04-11 CN disclosed
CN-119798589-A Polymeric resin and preparation method thereof, optical lens and intelligent glasses 珠海莫界科技有限公司 2025-04-11 CN disclosed
EP-3469073-B1 RAAV WITH CHEMICALLY MODIFIED CAPSID CENTRE NAT RECH SCIENT (FR) 2024-01-10 EP disclosed
US-11865185-B2 RAAV with chemically modified capsid CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2024-01-09 US disclosed
US-11648319-B2 rAAV with chemically modified capsid CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2023-05-16 US disclosed
US-20220193252-A1 RAAV WITH CHEMICALLY MODIFIED CAPSID CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2022-06-23 US disclosed
US-11278631-B2 RAAV with chemically modified capsid CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2022-03-22 US disclosed
US-20210283271-A1 RAAV WITH CHEMICALLY MODIFIED CAPSID CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2021-09-16 US disclosed
US-20210205467-A1 RAAV WITH CHEMICALLY MODIFIED CAPSID CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2021-07-08 US disclosed
EP-3469073-A1 RAAV WITH CHEMICALLY MODIFIED CAPSID CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2019-04-17 EP disclosed
WO-2017212019-A1 RAAV WITH CHEMICALLY MODIFIED CAPSID CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2017-12-14 WO disclosed
US-5310916-A Trifunctional agents useful as irreversible inhibitors of A1-adenosine receptors THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1994-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210283271-A1 RAAV WITH CHEMICALLY MODIFIED CAPSID IGF2R, CFH, M6PR TSHR 2872/4885NAPRT 813/4885TDP1 4742/4885
US-11278631-B2 RAAV with chemically modified capsid IGF2R, CFH, M6PR TSHR 2872/4885NAPRT 813/4885TDP1 4742/4885
US-20210205467-A1 RAAV WITH CHEMICALLY MODIFIED CAPSID IGF2R, CFH, M6PR TSHR 2872/4885NAPRT 813/4885TDP1 4742/4885
US-11648319-B2 rAAV with chemically modified capsid IGF2R, CFH, M6PR TSHR 2872/4885NAPRT 813/4885TDP1 4742/4885
US-11865185-B2 RAAV with chemically modified capsid COPB1, COPA, CRBN TSHR 2155/4885NAPRT 1042/4885TDP1 4144/4885
US-20220193252-A1 RAAV WITH CHEMICALLY MODIFIED CAPSID CFH, IGF2R, M6PR TSHR 3146/4885NAPRT 1039/4885TDP1 4753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.